Andrew McLean-Tooke

Summary

Affiliation: Freeman Hospital
Country: UK

Publications

  1. pmc Adrenaline in the treatment of anaphylaxis: what is the evidence?
    Andrew P C McLean-Tooke
    Regional Department of Immunology and Allergy, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
    BMJ 327:1332-5. 2003
  2. pmc Falsely normal C4 in a case of acquired C1 esterase inhibitor deficiency
    Andrew McLean-Tooke
    Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    J Clin Pathol 60:565-6. 2007
  3. doi request reprint Immunologic defects in 22q11.2 deletion syndrome
    Andrew McLean-Tooke
    Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    J Allergy Clin Immunol 122:362-7, 367.e1-4. 2008
  4. doi request reprint Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    Andrew McLean-Tooke
    Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Rheumatology (Oxford) 48:867-71. 2009

Detail Information

Publications4

  1. pmc Adrenaline in the treatment of anaphylaxis: what is the evidence?
    Andrew P C McLean-Tooke
    Regional Department of Immunology and Allergy, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
    BMJ 327:1332-5. 2003
  2. pmc Falsely normal C4 in a case of acquired C1 esterase inhibitor deficiency
    Andrew McLean-Tooke
    Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    J Clin Pathol 60:565-6. 2007
    ....
  3. doi request reprint Immunologic defects in 22q11.2 deletion syndrome
    Andrew McLean-Tooke
    Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
    J Allergy Clin Immunol 122:362-7, 367.e1-4. 2008
    ..These patients have variable defects in T-cell immunity with an increased incidence of infection and autoimmune disease...
  4. doi request reprint Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    Andrew McLean-Tooke
    Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Rheumatology (Oxford) 48:867-71. 2009
    ..Here we review the published data on the risks of infection associated with the use of MTX in patients with RA and make some recommendations for managing MTX in patients with infection...